ES2136124T3 - Derivados de carbapenem como antibioticos y sus productos intermedios. - Google Patents

Derivados de carbapenem como antibioticos y sus productos intermedios.

Info

Publication number
ES2136124T3
ES2136124T3 ES93906740T ES93906740T ES2136124T3 ES 2136124 T3 ES2136124 T3 ES 2136124T3 ES 93906740 T ES93906740 T ES 93906740T ES 93906740 T ES93906740 T ES 93906740T ES 2136124 T3 ES2136124 T3 ES 2136124T3
Authority
ES
Spain
Prior art keywords
alkyl
antibiotics
hydrogen
ring
intermediate products
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93906740T
Other languages
English (en)
Spanish (es)
Inventor
Frederic Henri Jung
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca SAS
Syngenta Ltd
Original Assignee
Zeneca Pharma SA
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeneca Pharma SA, Zeneca Ltd filed Critical Zeneca Pharma SA
Application granted granted Critical
Publication of ES2136124T3 publication Critical patent/ES2136124T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20Sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/568Four-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
ES93906740T 1992-03-26 1993-03-24 Derivados de carbapenem como antibioticos y sus productos intermedios. Expired - Lifetime ES2136124T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP92400836 1992-03-26
EP92402763 1992-10-09

Publications (1)

Publication Number Publication Date
ES2136124T3 true ES2136124T3 (es) 1999-11-16

Family

ID=26132349

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93906740T Expired - Lifetime ES2136124T3 (es) 1992-03-26 1993-03-24 Derivados de carbapenem como antibioticos y sus productos intermedios.

Country Status (24)

Country Link
US (1) US5519015A (fi)
EP (1) EP0586663B1 (fi)
JP (1) JP3313366B2 (fi)
KR (1) KR100283196B1 (fi)
CN (1) CN1036713C (fi)
AP (1) AP9300561A0 (fi)
AT (1) ATE185140T1 (fi)
AU (1) AU662972B2 (fi)
CA (1) CA2108356C (fi)
CZ (1) CZ254193A3 (fi)
DE (1) DE69326588T2 (fi)
DK (1) DK0586663T3 (fi)
ES (1) ES2136124T3 (fi)
FI (1) FI104075B (fi)
GB (1) GB9304156D0 (fi)
GR (1) GR3031340T3 (fi)
HU (1) HUT65713A (fi)
IL (1) IL105135A (fi)
MW (1) MW11393A1 (fi)
NO (1) NO303938B1 (fi)
NZ (1) NZ249947A (fi)
SK (1) SK132193A3 (fi)
WO (1) WO1993019070A1 (fi)
ZW (1) ZW3493A1 (fi)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9202298D0 (en) * 1992-02-04 1992-03-18 Ici Plc Antibiotic compounds
CA2106330A1 (en) * 1992-10-07 1994-04-08 Patrice J. Siret Antibiotic compounds
WO1994029313A1 (en) * 1993-06-16 1994-12-22 Sumitomo Pharmaceuticals Company, Limited NOVEL β-LACTAM COMPOUND AND PROCESS FOR PRODUCING THE SAME
GB9515975D0 (en) 1995-08-04 1995-10-04 Zeneca Ltd Chemical compounds
EP0923545A1 (en) 1996-08-17 1999-06-23 Zeneca Limited 3-mercaptopyrrolidines as farnesyl protein transferase inhibitors
JPH1077285A (ja) 1996-09-04 1998-03-24 Sumitomo Pharmaceut Co Ltd 新規なβ−ラクタム化合物およびその製造法
GB9930317D0 (en) 1999-12-22 2000-02-09 Zeneca Ltd Novel compounds
GB9930318D0 (en) 1999-12-22 2000-02-09 Zeneca Ltd Novel compounds
CN101367812B (zh) * 2007-06-28 2011-04-27 山东轩竹医药科技有限公司 被巯基吡咯烷甲酰胺基环戊烯酸取代的培南衍生物
CN101372490B (zh) * 2007-08-15 2011-02-09 山东轩竹医药科技有限公司 含有巯基氮杂环乙烯基氮杂环的培南衍生物
BRPI0905681A2 (pt) * 2008-01-08 2015-07-07 Purdue Pharma Lp "análogos da prolina como ligantes para receptores de canabinóide"
CN101613352B (zh) * 2008-06-25 2013-03-27 山东轩竹医药科技有限公司 含有甲酰胺杂环基巯基吡咯烷的培南衍生物
IT201800009385A1 (it) 2018-10-11 2020-04-11 Isagro Spa Derivati caffeinici ad attività nematocida, loro composizioni agronomiche e relativo uso
IT201900001339A1 (it) 2019-01-30 2020-07-30 Isagro Spa Derivati teofillinici ad attività nematocida, loro composizioni agronomiche e relativo uso
CN113666907A (zh) * 2021-08-25 2021-11-19 都创(上海)医药开发有限公司 一种基于微通道反应技术快速制备4-硝基噻吩-2-甲酸的方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0017992A1 (en) * 1979-04-19 1980-10-29 Merck & Co. Inc. 2-Substituted-6-substituted-1-carbadethiapen-2-em-3-carboxylic acids, processes for preparing them, antibiotic pharmaceutical compositions containing same and process for preparing intermediates
CA1283906C (en) * 1983-05-09 1991-05-07 Makoto Sunagawa .beta.-LACTAM COMPOUNDS AND PRODUCTION THEREOF
JPS60202886A (ja) * 1984-03-27 1985-10-14 Sankyo Co Ltd 1―置換カルバペネム―3―カルボン酸誘導体
JPS60233076A (ja) * 1984-05-03 1985-11-19 Sumitomo Chem Co Ltd 新規なβ−ラクタム化合物およびその製造法
EP0182213B1 (en) * 1984-11-08 1990-09-26 Sumitomo Pharmaceuticals Company, Limited Carbapenem compounds and production thereof
EP0243686B1 (en) * 1986-03-27 1992-07-15 Sumitomo Pharmaceuticals Company, Limited Beta-lactam compounds, and their production
US4963544A (en) * 1988-05-23 1990-10-16 Fujisawa Pharmaceutical Company, Ltd. 3-pyrrolidinylthio-1-azabicyclo[3.2.0]-hept-2-ene-2-carboxylic acid compounds
US5194624A (en) * 1988-05-23 1993-03-16 Fujisawa Pharmaceutical Co., Ltd. Intermediates for the preparation of compounds of antimicrobial activity
GB8923844D0 (en) * 1989-10-23 1989-12-13 Fujisawa Pharmaceutical Co Carbapenem compounds
CA2036941A1 (en) * 1990-02-23 1991-08-24 Isao Kawamoto Carbapenem derivatives having antibiotic activity, their preparation and their use
AU644008B2 (en) * 1990-08-10 1993-12-02 Sumitomo Pharmaceuticals Company, Limited Beta-lactam compounds, and their production and use
GB9107341D0 (en) * 1991-04-08 1991-05-22 Ici Plc Antibiotic compounds
RU2093514C1 (ru) * 1991-06-04 1997-10-20 Санкио Компани Лимитед Производные 1-метилкарбапенема и способ их получения

Also Published As

Publication number Publication date
FI104075B1 (fi) 1999-11-15
IL105135A0 (en) 1993-07-08
FI104075B (fi) 1999-11-15
CA2108356A1 (en) 1993-09-27
ZW3493A1 (en) 1994-03-02
FI935245A (fi) 1993-11-25
GR3031340T3 (en) 1999-12-31
HU9303304D0 (en) 1994-03-28
NZ249947A (en) 1996-02-27
HUT65713A (en) 1994-07-28
EP0586663A1 (en) 1994-03-16
MW11393A1 (en) 1994-06-08
ATE185140T1 (de) 1999-10-15
CN1036713C (zh) 1997-12-17
CA2108356C (en) 2004-01-20
SK132193A3 (en) 1994-11-09
CZ254193A3 (en) 1994-04-13
AU3763693A (en) 1993-10-21
IL105135A (en) 2000-01-31
GB9304156D0 (en) 1993-04-21
DK0586663T3 (da) 2000-04-10
JPH06508372A (ja) 1994-09-22
CN1077957A (zh) 1993-11-03
AU662972B2 (en) 1995-09-21
AP9300561A0 (en) 1995-02-26
DE69326588D1 (de) 1999-11-04
KR100283196B1 (ko) 2001-03-02
JP3313366B2 (ja) 2002-08-12
FI935245A0 (fi) 1993-11-25
NO934264L (no) 1993-11-25
WO1993019070A1 (en) 1993-09-30
US5519015A (en) 1996-05-21
NO934264D0 (no) 1993-11-25
DE69326588T2 (de) 2000-01-20
EP0586663B1 (en) 1999-09-29
NO303938B1 (no) 1998-09-28

Similar Documents

Publication Publication Date Title
ES2136124T3 (es) Derivados de carbapenem como antibioticos y sus productos intermedios.
SE7601205L (sv) Derivat av omettade aminosyror
PT1369409E (pt) Sais do acido boronico e sua utilizacao na preparacao de medicamentos para o tratamento da trombose
ES2011210T3 (es) Derivados de gem-difosfonato substituido, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
AR008377A1 (es) Un compuesto derivado de la 3-aroilbencilpiridazinona, una composicion farmaceutica particularmente para el tratamiento de enfermedades inflamatorias o autoinmunes que contiene dicho compuesto
ES2081187T3 (es) Nuevas naftil-alquil-aminas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
MX9303441A (es) Procedimiento para la preparacion de acido clavulanico.
ES2115058T3 (es) Derivados basicos de acido glutamico y acido aspartico como antagonistas de la gastrina o colecistoquinina.
ES2179996T3 (es) Cefalosporinas de vinil-pirrolidinona con sustituyentes basicos.
AR002751A1 (es) Antifungicos de tetrahidrofurano, composiciones farmaceuticas que los contienen y el uso de los compuestos para preparar composiciones farmaceuticas utiles para el tratamiento de infecciones fungicas
PT88070A (pt) Processo para a preparacao de compostos antibioticos a base de cefalosporinas e de composicoes farmaceuticas que os contem
MX9303124A (es) Compuestos organicos de benzodiazepina, procedimiento para su preparacion y formulaciones farmaceuticas que los contienen.
ES2171428T3 (es) Derivados de galantamina, un procedimiento para su preparacion y su uso como medicamentos.
ES2062143T3 (es) Derivados de pirrol sustituidos con grupos acriloilo y procedimiento para su preparacion.
PT92700A (pt) Processo para a preparacao de derivados de ciclo-alcano e de composicoes farmaceuticas que os contem
NO985516L (no) Nye naftalenforbindelser, en fremgangsmÕte ved deres fremstilling og farmas°ytiske sammensetninger inneholdende dem
AR001931A1 (es) Compuesto de 7-acilamino-3-iminometil (sustituido)cefalosporinas un proceso para su producción intermediarios en su producción una composición farmacéutica que contiene tales compuestos su utilizacióncomo compuestos farmacéuticos y un método para tratar enfermedades microbianas mediante administración de tales compuestos
SE8604950L (sv) Demensforbettrande och terapeutiska medel
AR019482A1 (es) DERIVADOS SUSTITUIDOS DEL 2-IMIDAZO(5,1-b)TIAZOL-CARBAPENEM, LAS COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN Y EL USO DE DICHOS DERIVADOS PARA LAPREPARACION DE MEDICAMENTOS
IE873037L (en) Antibiotic compounds
MX9201279A (es) Derivados de 1-fenil-3-aza bi ciclo alquil-imidazolidin-2-onas, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
ES2122221T3 (es) Compuestos terapeuticos adecuados para el tratamiento de enfermedades conectadas con la deficiencia de glutation, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
PA8475701A1 (es) Derivados de 3(2-oxo-[1,3']bipirrolidinil-3-ilidenmetil)-cephems
MX9203712A (es) Derivados de benzanilida y composiciones farmaceuticas que los contienen.
DE69424524D1 (de) Neue cephem-derivate

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 586663

Country of ref document: ES